Punjab Chemicals And Crop Protec (BSE: 506618) is a Mumbai, Maharashtra-based company in the Crop Protection Chemicals industry. With a market capitalisation of ₹1,226 Cr, it ranks #1,478 by market cap among the 6,137 Indian listed companies on FinBizNet, and #18 of 45 in Crop Protection Chemicals. At ₹966.80 (as of 25 Oct 2026), the share price is 37.0% below its 52-week high of ₹1,533.90 and 10.3% above its 52-week low of ₹876.60. The share price is down 28.2% over one year and down 13.8% over three months.
| Current Price | ₹966.80 |
|---|---|
| Market Cap | ₹1,226 Cr |
| BSE Code | 506618 |
| Sector | Materials > Chemicals > Fertilizers & Agri Chemicals |
| Sub-Industry | Fertilizers and Agricultural Chemicals > Crop Protection Chemicals |
| P/E Ratio | 18.9 |
| Return on Equity | 16.23% |
| Return on Assets | 6.91% |
| 52-Week Range | ₹876.60 – ₹1,533.90 |
| 1-Year Price Change | -28.2% |
| 3-Month Price Change | -13.8% |
| Beta (1Y) | 0.76 |
| Dividend Yield | 0.30% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.punjabchemicals.com |
| Revenue | ₹347 Cr |
|---|---|
| Net Profit | ₹22 Cr |
| Net Margin | 6.4% |
| EPS (Basic) | ₹18.00 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Punjab Chemicals and Crop Protection Limited manufactures and sells agrochemicals, specialty chemicals, bulk drugs, and related intermediates in India, Europe, Japan, Israel, the United States, Latin America, and internationally. It offers herbicides, including metamitron, ethofumesate, diflufenican, lenacil, and cyanazine; insecticides and fungicides; pharma active pharmaceutical ingredients (API) comprising trimethoprim IP/BP/USP/EP, etoricoxib, celecoxib, albendazole USP/BP/IP, drotaverine HCL; and pharma intermediates, advance intermediates for API, and antioxidants. The company provides fine and specialty chemicals; basic and industrial chemicals, such as oxalates and intermediates; and phosphorus derivatives and phosphates. In addition, it is involved in international trading of chemicals; and provision of research and development and contract manufacturing services. The company was incorporated in 1975 and is based in Mumbai, India.
1. Performance Chemicals-This segment engages in manufacturing agro chemicals, specialty chemicals, and bulk drugs and its intermediates. 2. Bulk Drug & Intermediates-This segment manufactures bulk drugs and intermediates. 3. Inter Segment Revenue-0 4. Unallocated Assets-0
1. Performance Chemicals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| United Phosphorus Ltd. (UPL) | ₹45,036 Cr | 23.7 | 5.61% | ₹10,181 Cr | -25.2% |
| PI Industries Ltd | ₹33,205 Cr | 24.8 | 12.35% | ₹1,702 Cr | -42.2% |
| Sumitomo Chemicals India Ltd | ₹20,203 Cr | 36 | 17.24% | ₹1,063 Cr | -30.3% |
| Bayer Cropscience Ltd | ₹16,360 Cr | 23.2 | 23.70% | ₹1,835 Cr | -33.8% |
| Eid Parry India Ltd | ₹12,315 Cr | 21.1 | 9.91% | ₹9,018 Cr | -39.2% |
| Sharda Cropchem Ltd | ₹6,544 Cr | 9.2 | 24.16% | ₹1,074 Cr | -22.0% |
| Rallis India Ltd. | ₹3,985 Cr | 21.6 | 9.32% | ₹858 Cr | -31.6% |
| Dhanuka Agritech Ltd | ₹3,867 Cr | 13.6 | 18.62% | ₹462 Cr | -40.1% |
| Punjab Chemicals And Crop Protec | ₹1,226 Cr | 18.9 | 16.23% | ₹347 Cr | -28.2% |
Listed by market capitalisation. Ratios are shown for context only.
Punjab Chemicals And Crop Protec is trading at ₹966.80, with a market capitalisation of ₹1,226 Cr.
Punjab Chemicals And Crop Protec operates in the Materials > Chemicals > Fertilizers & Agri Chemicals space (Fertilizers and Agricultural Chemicals > Crop Protection Chemicals).
Punjab Chemicals And Crop Protec has a P/E of 18.9 and a return on equity of 16.23%.
Punjab Chemicals And Crop Protec is listed on the BSE under the scrip code 506618.
Punjab Chemicals And Crop Protec's share price is down 28.2% over one year and down 13.8% over three months. Its 52-week range is ₹876.60 to ₹1,533.90.
In Q1 FY27, Punjab Chemicals And Crop Protec reported revenue of ₹347 Cr and net profit of ₹22 Cr, with basic EPS of ₹18 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.